September 23, 2025

GRAIL, Inc. (GRAL) Investor Outlook: A Healthcare Innovator with a $1.6 Billion Market Cap

GRAIL, Inc. (GRAL), a pioneering force in the healthcare sector, is making waves with its advanced diagnostics and research solutions. Headquartered in Menlo Park, California, this commercial-stage company is well-regarded..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 35.31% Upside Potential Amidst Healthcare Innovations

HUTCHMED (China) Limited (NASDAQ: HCM) is carving a niche in the global healthcare sector, focusing on the discovery and commercialization of targeted therapeutics and immunotherapies. Despite recent challenges, including a..

Janux Therapeutics, Inc. (JANX): Investor Outlook on a Biotech with a 234% Potential Upside

As investors navigate the complex landscape of biotechnology stocks, Janux Therapeutics, Inc. (NASDAQ: JANX) emerges as a compelling candidate for those seeking high-growth potential. With its innovative approach to cancer..

Kestra Medical Technologies (KMTS) Stock Analysis: Impressive Revenue Growth with Significant Upside Potential

Investors eyeing the healthcare sector should pay close attention to Kestra Medical Technologies, Ltd. (KMTS), a dynamic player in the medical instruments and supplies industry. With its focus on wearable..

Surgery Partners, Inc. (SGRY): Investor Outlook on a Potential 40.92% Upside

Surgery Partners, Inc. (NASDAQ: SGRY) has positioned itself as a significant player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the company operates..

NeoGenomics, Inc. (NEO) Stock Analysis: Uncovering a Potential 19% Upside in the Diagnostics Sector

NeoGenomics, Inc. (NEO), a prominent player in the healthcare sector, has carved a niche in the diagnostics and research industry with its specialized cancer-focused testing laboratories. Operating across the United..

Integra LifeSciences Holdings (IART) Stock Analysis: A Deep Dive into its 10.17% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, operates within the specialized industry of medical devices. Headquartered in Princeton, New Jersey, Integra LifeSciences has carved..

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 15.58% Potential Upside for Investors

Investors with a keen eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing prospect. With its specialized focus on health information services, the company has..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating the CNS Drug Maker’s Market Position and Growth Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector specializing in drug manufacturing for central nervous system (CNS) diseases, has been capturing investor interest. With a current..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 88% Upside in the Biotech Space

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of biotechnology, is capturing investor attention with its innovative approach to precision genetic medicines. Headquartered in Cambridge, Massachusetts, Beam Therapeutics..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Leading Biotech with an 8.75% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to developing peptide therapeutics for complex hematology, blood disorders, and..

Privia Health Group, Inc. (PRVA): Investor Outlook Reveals 32% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a noted player in the healthcare sector, is drawing significant investor attention with its promising growth prospects and strategic positioning in the health information..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Analyst Consensus Pointing to a 23.81% Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) operates at the fascinating intersection of healthcare and technology, specifically within the medical instruments and supplies industry. With a market capitalization of $1.21 billion, this..

Brookdale Senior Living Inc. (BKD): Investor Outlook Amidst Strong Revenue Growth and Challenging Valuations

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in providing senior living communities across the United States. Despite its extensive market presence and a..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 40.92% Potential Upside in the Biotech Sector

Investors keen on exploring opportunities in the biotechnology sector should consider Novavax, Inc. (NASDAQ: NVAX), a company renowned for its innovative vaccine technologies. Headquartered in Gaithersburg, Maryland, Novavax is at..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring Upside Potential with a 16.80% Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical care facilities industry. This Atlanta-based company, with a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking a 47% Upside Potential

Investors with an eye for growth opportunities in the biotech sector might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market cap of $2.88 billion and a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors with a tantalizing 25% potential upside. As a global biopharmaceutical company headquartered in Bridgewater,..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 125% Potential Upside in Clinical-Stage Biotech

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This clinical-stage biopharmaceutical company, established in 2018 and based in San Francisco,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a 282% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a key player in the biotechnology sector, is garnering considerable attention from investors due to its robust growth potential and promising therapeutic developments. With a market..

Search

Funds

September 23, 2025

Search

Funds

September 23, 2025

FTSE 100

Funds